Capital Ketamine

Capital Ketamine (Baton Rouge, LA) is a SAMHSA Behavioral Health Treatment Services Locator-registered facility. The facility offers a continuum of care across multiple levels — Detox, Inpatient, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. Evaluation of this facility against current clinical standards should encompass ASAM 4e framework alignment, MAT policy, and payer-specific network status.

Care levels at Capital Ketamine

The facility offers a continuum of care across multiple levels — Detox, Inpatient, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. Operational prerequisite for admission: documented clinical assessment establishing medical necessity for the specific level of care Capital Ketamine provides. The ASAM Criteria 4e framework is the benchmark standard for this assessment and is referenced in most major payer medical-necessity documents.

Insurance and payment

Capital Ketamine accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. Benefit verification should be obtained in writing prior to admission and should document: network contract status for the specific insurance product, prior authorization requirements and approved day-count, applicable cost-sharing structure, and out-of-network secondary coverage (where applicable). Proceeding on verbal VOB creates material risk of post-admission benefit dispute.

Specialty programming

The facility's documented specialty programming includes: Adult women, Adult men, Clients with co-occurring mental and substance use disorders. Evaluation of specialty-program alignment requires documented review of clinical team credentials, specialty-specific programming hours, and integrated assessment protocols. Specialty designation without documented clinical infrastructure is a recognized marketing pattern in the sector.

Before you call

Pre-admission due-diligence for Capital Ketamine: (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via LA behavioral-health regulator inspection records. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.